Horribly inaccurate PPS prediction before AHA 2018. Direct refutation of his claim of not predicting PT
Prior post on approval flow for EMA. He constantly shifts his timeline, but has claimed in arguments that there have been no delays (despite the obvious schedule slips)
His latest post was a direct misrepresentation of the facts. Same as claiming management has sold millions of shares on the open market when they are selling shares awarded to them as sales plan. Conversion and sale is not equal to an open market sale of an existing position.